KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Jun 02, 2021 $174.92 $176.09 $174.92 $175.51 1 789 518
Jun 01, 2021 $177.43 $177.69 $175.36 $175.86 2 900 431
May 28, 2021 $176.75 $178.43 $176.44 $176.55 1 050 249
May 27, 2021 $175.76 $177.91 $175.43 $177.03 2 862 269
May 26, 2021 $177.11 $177.93 $175.95 $176.10 1 273 184
May 25, 2021 $177.74 $177.87 $176.77 $177.10 1 506 028
May 24, 2021 $178.20 $178.71 $177.98 $178.04 1 445 147
May 21, 2021 $178.07 $178.66 $176.76 $177.72 1 990 950
May 20, 2021 $176.11 $179.12 $176.11 $178.36 2 062 742
May 19, 2021 $175.29 $175.72 $174.61 $175.47 3 880 989
May 18, 2021 $175.00 $175.73 $174.87 $174.87 1 473 683
May 17, 2021 $173.79 $175.08 $173.78 $174.75 1 373 564
May 14, 2021 $173.59 $174.15 $173.45 $173.49 1 417 833
May 13, 2021 $172.06 $173.86 $171.85 $173.33 1 340 506
May 12, 2021 $172.00 $173.24 $171.80 $171.99 2 051 387
May 11, 2021 $170.93 $171.81 $169.94 $171.41 2 364 319
May 10, 2021 $171.79 $172.59 $171.18 $171.81 1 890 835
May 07, 2021 $170.00 $171.15 $169.73 $170.43 1 202 012
May 06, 2021 $169.52 $169.93 $168.58 $169.86 1 597 590
May 05, 2021 $169.30 $169.95 $168.77 $169.91 1 666 606
May 04, 2021 $169.54 $169.69 $168.11 $168.49 2 999 343
May 03, 2021 $168.51 $170.29 $168.51 $170.27 2 510 463
Apr 30, 2021 $168.98 $172.08 $168.06 $168.68 3 469 279
Apr 29, 2021 $166.75 $166.97 $164.83 $165.58 1 568 009
Apr 28, 2021 $167.02 $167.48 $166.25 $166.73 1 258 826
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT